Fosamax, or alendronate, is a bisphosphonate chemically, and among a special class of calcium regulators. This drug is generally prescribed for the prevention or treatment of osteoporosis, although several brittle bone diseases may benefit from its use. According to Drugs.com, it is available in both tablet and liquid forms ranging from 5 to 40 mg in a daily dose and 70 mg in a weekly dose. This medication is not for everyone, as certain medical conditions may prohibit its effectiveness, or it may have contraindications with other medications. It is imperative to discuss medical history and options with a licensed medical professional before attempting to self-medicate.
Osteoporosis--Women
Fosamax is most often prescribed for the prevention and treatment of osteoporosis in post-menopausal women. Post-menopausal women are prone to thinning of the bones, resulting in hip and spinal fractures. This medication helps to lower those risks by building bone mass. Physicians' Desktop Reference further suggests that women--and men--taking glucocorticoids for conditions such as arthritis may reap extra benefits from taking this medication.
Osteoporosis--Men
Men are also prone to getting osteoporosis. Although not as commonly as women, men suffer from thinning bones, and hip and spinal fractures, as a result of accidents or falls. Drug Information Portal suggests that Fosamax is generally successful at building bone mass in men, and can be especially beneficial for men of smaller statures. This drug can be used as a preventative measure and for disease treatment.
Paget's Disease
Paget's disease is a debilitating painful condition in which the bones become severely deformed or weakened. Physicians' Desk Reference suggests that this disease occurs in females and males equally. Fosamax for this condition is usually prescribed at the higher end of dosing at about 40 mg every day for six months. Fosamax is not recommended for the treatment of children with Paget's disease.
